And fundamentally what we're doing is creating a pattern interrupt. This is significantly different than what others have done to achieve lower costs because again, We are taking out the middlemen and we are fundamentally reducing the cost to individuals, ultimately extending that to taxpayers themselves. And so I just want to extend gratitude to all of our partners to this process that continues, including some FDA approvals that are in front of us next year, … (13:42–13:53)
CLAIM
Asserts that the initiative removes middlemen to reduce costs for individuals and taxpayers.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
.jpg)